NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Continue to BS, gaslight and mislead as always. There are quite a few pre revenue biotech that continue upwards trajectory in terms of share price because they are able to execute relentlessly and build strong confidence in the investment community. They build a compelling business narrative and are able to present that crisply to institutional investors. This management team cant even control whats in their hands which is to apply to multiple regulators as well as submit reimbursement evidence 4 years since data lock. Market makers are preventing them from submitting reimbursement evidence or applying in other jurisdictions.